Parmar Kush (CIK 0001664281)

Latest company ownership

Shares held
1,899,157
Last filed at
Oct 7, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
1,093,313
Last filed at
Nov 18, 2025
Confidence Score
20.9
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
635,341
Last filed at
Feb 16, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
CABA - Cabaletta Bio, Inc.
Role: 10% Owner
Shares held
333,144
Last filed at
Nov 3, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
302,770
Last filed at
Oct 15, 2024
Confidence Score
59.5
2025Q4
Confidence Score History
2024Q4 2025Q4
Shares held
214,692
Last filed at
Jul 24, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
66,277
Last filed at
Sep 13, 2024
Confidence Score
44.4
2025Q4
Confidence Score History
2024Q1 2025Q4
QTTB - Q32 Bio Inc.
Role: Director
Shares held
18,000
Last filed at
Jun 17, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4
VOR - Vor Biopharma Inc.
Role: Director
Shares held
16,911
Last filed at
Jun 16, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
RLYB - Rallybio Corp
Role: Director
Shares held
16,500
Last filed at
May 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 14, 2025 Nov 18, 2025 Entrada Therapeutics, Inc. Director Sell 17.5 -200,000 -4.70% ✗ $1.8M
Sep 11, 2025 Sep 15, 2025 Camp4 Therapeutics Corp 10% Owner Buy 100.0 +2,941,176 100.45% ✗ $4.5M
Aug 21, 2025 Aug 22, 2025 Skye Bioscience, Inc. 10% Owner Sell 20.0 -231,405 -2.33% ✗ $800.5K
Jul 9, 2025 Jul 11, 2025 Entrada Therapeutics, Inc. Director Sell 32.5 -27,000 -0.63% ✗ $202.6K
Jun 27, 2025 Jul 1, 2025 Entrada Therapeutics, Inc. Director Sell 20.0 -125,000 -2.84% ✗ $866.6K
Oct 15, 2024 Oct 15, 2024 Camp4 Therapeutics Corp 10% Owner Buy 100.0 +909,090 52.98% ✗ $10M
Sep 11, 2024 Sep 13, 2024 Skye Bioscience, Inc. 10% Owner Sell 17.5 -266,337 -2.62% ✗ $1.8M
Jul 22, 2024 Jul 24, 2024 Artiva Biotherapeutics, Inc. 10% Owner Buy 100.0 +1,295,020 122.37% ✗ $14.7M
Mar 13, 2024 Mar 15, 2024 Skye Bioscience, Inc. 10% Owner Buy 92.5 +450,000 4.63% ✗ $4.5M
Feb 14, 2024 Feb 16, 2024 Enliven Therapeutics, Inc. 10% Owner Sell 15.0 -825,000 -17.70% ✗ $12.3M
Jan 31, 2024 Feb 2, 2024 Skye Bioscience, Inc. 10% Owner Buy 100.0 +5,206,074 115.09% ✗ $12M
Jan 31, 2024 Feb 2, 2024 Enliven Therapeutics, Inc. 10% Owner Sell 16.3 -500,000 -9.69% ✗ $7.5M
Sep 26, 2023 Sep 28, 2023 Enliven Therapeutics, Inc. 10% Owner Sell 17.5 -197,500 -3.69% ✗ $3M
Aug 24, 2023 Aug 28, 2023 Enliven Therapeutics, Inc. 10% Owner Sell 16.3 -440,000 -7.59% ✗ $7M
Mar 7, 2023 Mar 9, 2023 Rallybio Corp Director Sell 20.0 -100,000 -2.68% ✗ $820K
Jun 3, 2022 Jun 7, 2022 Rallybio Corp Director Sell 17.5 -150,000 -3.87% ✗ $1.9M
May 23, 2022 May 25, 2022 Rallybio Corp Director Sell 17.5 -100,000 -2.51% ✗ $1.3M
Feb 8, 2022 Feb 10, 2022 Rallybio Corp Director Sell 17.5 -210,000 -5.01% ✗ $2.7M
Nov 16, 2021 Nov 18, 2021 Vor Biopharma Inc. Director Sell 16.3 -330,706 -4.94% ✗ $5.1M
Nov 2, 2021 Nov 5, 2021 Entrada Therapeutics, Inc. Director Buy 100.0 +250,000 28.33% ✗ $5M
Nov 1, 2021 Nov 3, 2021 Cabaletta Bio, Inc. 10% Owner Sell 17.5 -295,000 -12.50% ✗ $3.8M
Sep 7, 2021 Sep 9, 2021 Cabaletta Bio, Inc. 10% Owner Sell 16.3 -625,000 -23.90% ✗ $6.1M
Jul 28, 2021 Aug 4, 2021 Rallybio Corp Director Buy 100.0 +4,190,724 100.00% ✗ $8M
Feb 9, 2021 Feb 9, 2021 Vor Biopharma Inc. Director Buy 96.3 +555,555 9.05% ✗ $10M
Jan 8, 2021 Jan 12, 2021 Cabaletta Bio, Inc. 10% Owner Sell 16.3 -387,000 -6.01% ✗ $5M
Dec 22, 2020 Dec 28, 2020 Q32 Bio Inc. Director Sell 16.3 -500,000 -9.93% ✗ $6.4M
Dec 14, 2020 Dec 16, 2020 Q32 Bio Inc. Director Sell 16.3 -500,000 -4.58% ✗ $6.1M
Dec 10, 2020 Dec 14, 2020 Cabaletta Bio, Inc. 10% Owner Sell 17.5 -298,000 -8.12% ✗ $4.4M
Oct 5, 2020 Oct 7, 2020 Aprea Therapeutics, Inc. Other Sell 17.5 -175,000 -55.82% ✗ $4.4M
Jun 16, 2020 Jun 18, 2020 Aprea Therapeutics, Inc. 10% Owner Sell 17.5 -140,000 -5.95% ✗ $4.7M
Jun 11, 2020 Jun 15, 2020 Aprea Therapeutics, Inc. 10% Owner Sell 16.3 -245,000 -10.82% ✗ $7M
May 19, 2020 May 21, 2020 Aprea Therapeutics, Inc. 10% Owner Sell 16.3 -255,000 -10.12% ✗ $9M
Oct 29, 2019 Oct 31, 2019 Cabaletta Bio, Inc. 10% Owner Buy 100.0 +454,545 100.00% ✗ $5M
Oct 7, 2019 Oct 9, 2019 Aprea Therapeutics, Inc. 10% Owner Buy 100.0 +333,333 100.00% ✗ $5M
May 16, 2019 May 20, 2019 Q32 Bio Inc. Director Sell 15.0 -615,000 -10.00% ✗ $13.2M
Dec 10, 2018 Dec 12, 2018 Q32 Bio Inc. Director Sell 37.5 -15,575 -0.25% ✗ $405K
Nov 23, 2018 Nov 27, 2018 Q32 Bio Inc. Director Sell 37.5 -29,682 -0.48% ✗ $594.7K
Nov 16, 2018 Nov 20, 2018 Q32 Bio Inc. Director Sell 15.0 -525,900 -7.82% ✗ $10.6M